Plasma neuropeptide-Y levels, monoamine metabolism, electrolyte excretion and drinking behavior in children with attention-deficit hyperactivity disorder
暂无分享,去创建一个
R. Oades | W. Rascher | Robert D Oades | W Rascher | R Daniels | R. Daniels
[1] M. Fregly,et al. Effect of administration of angiotensin II and isoproterenol, alone and in combination, on drinking and tail skin temperature of the rat , 1995, Pharmacology Biochemistry and Behavior.
[2] Rémi Quirion,et al. Neuropeptide Y and neuropeptide Y receptor subtypes in brain and peripheral tissues , 1992, Progress in Neurobiology.
[3] R. Oades,et al. A test of conditioned blocking and its development in childhood and adolescence : Relationship to personality and monoamine metabolism , 1996 .
[4] D. Erlinge,et al. Neuropeptide Y-like immunoreactivity and hypertension , 1992, Journal of hypertension.
[5] R. Oades,et al. Auditory event-related potentials (ERPs) and mismatch negativity (MMN) in healthy children and those with attention-deficit or tourette/tic symptoms , 1996, Biological Psychology.
[6] P. Pruszczyk,et al. Plasma neuropeptide Y during dynamic exercise in patients with essential hypertension. , 1995, Clinical and experimental hypertension.
[7] W. Rascher,et al. Serial measurements of neuropeptide Y in plasma for monitoring neuroblastoma in children. , 1993, The Journal of pediatrics.
[8] F. Brucker-Davis,et al. Thyroid hormones correlate with symptoms of hyperactivity but not inattention in attention deficit hyperactivity disorder , 1997, Psychoneuroendocrinology.
[9] C. Conners. Attention Deficit Disorder: Clinical and Basic Research , 1991 .
[10] R. Oades. Attention deficit disorder with hyperactivity (ADDH): The contribution of catecholaminergic activity , 1987, Progress in Neurobiology.
[11] F Fazekas,et al. Magnetic resonance imaging white matter lesions and cognitive impairment in hypertensive individuals. , 1991, Archives of neurology.
[12] B. Müller,et al. The development of conditioned blocking and monoamine metabolism in children with attention-deficit-hyperactivity disorder or complex tics and healthy controls: an exploratory analysis , 1997, Behavioural Brain Research.
[13] D. Trudeau,et al. Determination of calcium in urine and serum by atomic absorption spectrophotometry (AAS). , 1967, Clinical chemistry.
[14] F Xavier Castellanos,et al. Cerebrospinal Fluid Homovanillic Acid Predicts Behavioral Response to Stimulants in 45 Boys with Attention Deficit/Hyperactivity Disorder , 1996, Neuropsychopharmacology.
[15] J. Rapoport,et al. Thyroid function and attention-deficit hyperactivity disorder. , 1994, Journal of the American Academy of Child and Adolescent Psychiatry.
[16] M. Javors,et al. Urinary catecholamines in attention-deficit hyperactivity disorder with and without comorbid anxiety. , 1994, Journal of the American Academy of Child and Adolescent Psychiatry.
[17] M. Hariharan,et al. Urinary epinephrine excretion during intelligence testing in attention-deficit hyperactivity disorder and normal boys , 1996, Biological Psychiatry.
[18] B. Leventhal,et al. Attention deficit hyperactivity disorder and whole-blood serotonin levels: effects of comorbidity , 1995, Psychiatry Research.
[19] P. J. Graham,et al. Effects of a few food diet in attention deficit disorder. , 1993, Archives of disease in childhood.
[20] R. J. Leo,et al. Utility of thyroid function screening in adolescent psychiatric inpatients. , 1997, Journal of the American Academy of Child and Adolescent Psychiatry.
[21] K. Fuxe,et al. Neuropeptide Y/angiotensin II interactions in central cardiovascular regulation of the rat , 1991, Brain Research.
[22] T. O'donohue,et al. Amphetamine-induced changes in immunoreactive NPY in rat brain, pineal gland and plasma , 1985, Peptides.
[23] T. Lohmeier,et al. Blood pressure regulation: basic concepts. , 1981, Federation proceedings.
[24] W. Rascher,et al. Elevated plasma concentrations of neuropeptide Y in children and adults with chronic and terminal renal failure. , 1997, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[25] C. Best. Best and Taylor's Physiological basis of medical practice , 1985 .
[26] M. Campagnole-Santos,et al. Evidence that angiotensin-(1–7) plays a role in the central control of blood pressure at the ventro-lateral medulla acting through specific receptors , 1994, Brain Research.
[27] J. Markowitz,et al. Pharmacology of methylphenidate, amphetamine enantiomers and pemoline in attention‐deficit hyperactivity disorder , 1997 .
[28] J. Egger,et al. Controlled trial of hyposensitisation in children with food-induced hyperkinetic syndrome , 1992, The Lancet.
[29] S. Frankmann,et al. Differential changes in central monoaminergic metabolism during first and multiple sodium depletions in rats , 1994, Pharmacology Biochemistry and Behavior.
[30] T. Sagvolden,et al. Spontaneously hypertensive rats (SHR) as a putative animal model of childhood hyperkinesis: SHR behavior compared to four other rat strains , 1993, Physiology & Behavior.
[31] J. Herbert,et al. Regional suppression by water intake of c-fos expression induced by intraventricular infusions of angiotensin II , 1994, Brain Research.